Luyan PharmaLtd Salute del bilancio
Salute finanziaria criteri di controllo 4/6
Luyan PharmaLtd has a total shareholder equity of CN¥3.1B and total debt of CN¥5.0B, which brings its debt-to-equity ratio to 161.7%. Its total assets and total liabilities are CN¥12.4B and CN¥9.3B respectively. Luyan PharmaLtd's EBIT is CN¥705.6M making its interest coverage ratio 3.2. It has cash and short-term investments of CN¥481.5M.
Informazioni chiave
161.7%
Rapporto debito/patrimonio netto
CN¥5.01b
Debito
| Indice di copertura degli interessi | 3.2x |
| Contanti | CN¥481.54m |
| Patrimonio netto | CN¥3.10b |
| Totale passività | CN¥9.30b |
| Totale attività | CN¥12.40b |
Aggiornamenti recenti sulla salute finanziaria
Nessun aggiornamento
Analisi della posizione finanziaria
Passività a breve termine: 002788's short term assets (CN¥9.7B) exceed its short term liabilities (CN¥8.4B).
Passività a lungo termine: 002788's short term assets (CN¥9.7B) exceed its long term liabilities (CN¥868.5M).
Storia e analisi del rapporto debito/patrimonio netto
Livello di debito: 002788's net debt to equity ratio (146.1%) is considered high.
Riduzione del debito: 002788's debt to equity ratio has reduced from 176.7% to 161.7% over the past 5 years.
Copertura del debito: 002788's debt is not well covered by operating cash flow (17.3%).
Copertura degli interessi: 002788's interest payments on its debt are well covered by EBIT (3.2x coverage).